


BrainVectis raises €1 million to develop its gene therapy for Huntington’s and Alzheimer’s diseases

Alizé Pharma III presents preclinical results from its I-HBD1 program at the Annual Meeting of the American Society for Bone and Mineral Research

CiToxLAB appoints Alan Bartlett as Senior Director, Global Laboratory Operations

GamaMabs Pharma starts phase Ia/Ib study of first-in-class monoclonal antibody GM102 in advanced gynecological cancer

Alizé Pharma to present results from AZP-531 Phase II trial in Prader-Willi syndrome at two upcoming scientific conferences

Biomunex presents novel data confirming optimal drug-like properties and activity of BiXAb® antibodies
